NEWS & INFORMATION

29-September-2008

Cardiocore Appoints Bob Goodman as Vice President of Sales. Experienced Life Science Executive to Lead Cardiocore's Worldwide Sales Expansion.

27-July-2008 to 01-August-2008

Cardiocore Scientists present data from the first Thorough QT study performed on a statin drug for cholesterol reduction, at the IXth World Conference on Clinical Pharmacology and Therapeutics, in Quebec, Canada.

22-June-2008 to 26-June-2008

Cardiocore Scientists present data from the first Thorough QT study performed on a statin drug for cholesterol reduction, at the DIA's 44th Annual Meeting, at the Boston Convention Center.

09-April-2008

Cardiocore Chief Medical Officer presents "The Evolution of Thorough QT Study Designs," at the Cardiac Safety Education Center, in the Campbell University School of Pharmacy, at Research Triangle Park.

07-April-2008 and 08-April-2008

Cardiocore Senior Scientific Consultant presents unique results from Thorough QT study conducted for an international biopharmaceutical company, at the FDA & DIA's QT and Arrhythmia Issues in Drug Development Conference, in Bethesda, MD. Join Cardiocore, regulatory, industry and scientific leaders to explore and discuss the evolution of drug development and cardiac repolarization at this pre-eminent meeting.

23-January-2008 to 25-January-2008

Cardiocore Chief Medical Officer chairs a sponsor workshop entitled, "Advanced Topics in Cardiac Safety, Thorough QT and Regulatory Expectations," Cardiocore VP, Medical Operations presents, "The Value of Echocardiography in Clinical Trials," and Cardiocore Senior Scientist presents, "The Pros and Cons of ECG Algorithms," at the IIR's 6th Annual Partnering with Central Labs, ECG and Imaging Labs, in Orlando, Florida.

14-January-2008 to 15-January-2008

Cardiocore Chief Medical Officer co-chairs the CBI's Cardiac Safety Summit and discusses Key Thorough QT Design Issues. At this conference, Cardiocore VP, Medical Operations presents Cardiac Safety Testing in Oncology Drug Development, and Cardiocore Senior Scientist presents Strategic Planning for Cardiac Safety Testing, in Arlington, VA.

03-October-2007

Cardiocore expands its organization to include US west coast operation, providing greater access for west coast, Japanese and Australian clients.

17-September-2007

Cardiocore's VP, Medical Operations presents Echocardiographic Cardiac Safety Assessment for Oncology Drugs in the workshop titled, “Cardiac Safety in Oncology Drug Development - ICH E14 and Beyond,” at CBI’s Oncology Summit in Arlington, Virginia.

04-September-2007

Cardiocore Launches Centralized Echocardiography Offering.

29-August-2007

Cardiocore Acquires Experienced Cardiac Safety Team Formerly with Gentiae.

15-June-2007

Cardiocore Adds Daniel Goodman, MD to its Cardiac Safety Consulting Team. Fastest Growing Cardiac Core Lab Expands its International Scientific Leadership.

24-Apr-2007

Cardiocore's CEO, Jennifer Cotteleer presents Current Trends in Healthcare Information Technology at Georgetown University’s McDonough School of Business, in Washington, DC.

11-Apr-2007 thru 13-Apr-2007

Along with a team of industry experts, Cardiocore's CMO, Lawrence Satin, MD presents the advantages of cardiologist-read ECGs at the FDA/DIA QT Issues in Drug Development conference in Washington, DC.

13-Mar-2007 thru 15-Mar-2007

Cardiocore's CMO, Lawrence Satin, MD co-presents the ICH E14 post-conference workshop at IIR/Informa's QT Prolongation & Safety Pharmacology conference in Paris, France.

29-Jan-2007 thru 30-Jan-2007

Cardiocore’s CMO, Lawrence Satin, MD is an expert panelist discussing ICH E14—Clinical Implications and Execution at CBI’s Cardiac Safety Assessment Summit in Arlington, Virgnina.

17-Jan-2007 thru 19-Jan-2007

Cardiocore's CMO Lawrence Satin, MD chairs a day of presentations titled Best Practices in Outsourcing to ECG Core Labs at IIRs Partnering with Central Labs, ECG and Imaging Labs, in Anaheim, CA.

28-Nov-2006 thru 29-Nov-2006

Cardiocore’s CEO, Jennifer Cotteleer, presents advanced strategies for integration of ECG data management at VIB Events’ Cardiac Safety 2006 conference in London, England.

01-June-2006

FDA’s ECG Warehouse Architects recognize Cardiocore’s Innovative Application of ECG Technologies. Cardiocore named Mortara Certified Partner.

16-May-2006 thru 18-May-2006

Cardiocore's Lawrence Satin, MD (Chief Medical Officer) discusses the conduct of Thorough QT trials and the importance of core labs’ residual variability at the IIR’s Partnering with Central Labs, ECG and Imaging Labs in London, UK.

08-May-2006 thru 09-May-2006

Cardiocore's Lawrence Satin, MD (Chief Medical Officer) and Jane Gale of Bristol Myers Squibb co-present Three Key Areas of Research with ECG Warehouse at the FDA/ DIA co-sponsored Challenges and Practical Aspects of Assessing Clinical QT Prolongation/Proarrhythmia Risk and Implications for the Critical Pathway conference, in Washington, DC.

29-March-2006

Cardiocore raises $8 million in venture funding. Former Johnson & Johnson Vice Chairman and recognized life sciences entrepreneur expand Cardiocore’s expertise.